59
Participants
Start Date
April 30, 2021
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
Personalized rATG (P-rATG)
P-rATG days (always starting on Day -12 to -10)
Hyper fractionated total body irradiation
"(1375 - 1500cGy\*) Day -9 to -6~\*TBI dose in 125cGy fractions (with lung shielding) and total dose to be determined by treating physician/radiation oncology and is based off age, stage of disease, and anesthesia requirements."
Thiotepa
(5mg/kg/day x 2 day) Day -5 to -4
Cyclophosphamide
(60mg/kg/day x 2 days) Day -3 to -2
GCSF
Day +7
Busulfan
Day -9 to -7 doses 2-3 to be adjusted per PK for target cumulative exposure of 65 mg\*h/L
Melphalan
(70mg/m2/day x 2 days) Day -6 to -5
Fludarabine
(25mg/m2/day x 5 days) Day -6 to -2
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center
OTHER